Quan Anh Vu - 30 Jun 2026 Form 4 Insider Report for Monopar Therapeutics (MNPR)

Reporting relationship: Chief Financial Officer
Issuer ticker: MNPR
Reported as of: 30 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jul 2026, 19:38:27 UTC
Prior SEC filing: 29 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Quan Vu

Key filing fact

Quan Anh Vu filed Form 4 for Monopar Therapeutics (MNPR) on 02 Jul 2026.

Key facts

This page summarizes Quan Anh Vu's Form 4 filing for Monopar Therapeutics (MNPR).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 02 Jul 2026, 19:38.

Change

Previous filing in this sequence was filed on 29 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001892297 Primary reporting owner

Vu Quan Anh

Relationship: Chief Financial Officer
Address: 1000 SKOKIE BLVD SUITE 350, WILMETTE
Signature: /s/ Quan Vu
Signature date: 02 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MNPR transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,228
Change %: +82%
Price
Shares after: 2,728
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F1

MNPR transaction

Common Stock

Tax liability

Transaction value
Shares: -507
Change %: -19%
Price: $92.59^*
Shares after: 2,221
Date: 30 Jun 2026
Ownership: Direct
Footnotes: F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MNPR transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -1,228
Change %: -12%
Price: $0.000000^*
Shares after: 8,598
Date: 30 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,228
Exercise price
Footnotes: F1, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents shares acquired on vesting and settlement of restricted stock units.

Footnote F2

Represents shares withheld by the issuer to pay for the applicable withholding tax due upon vesting of restricted stock units.

Footnote F3

On December 2, 2025, the reporting person was granted 9,826 restricted stock units, vesting 6/48ths (1,228) on June 30, 2026, and 3/48ths (614 shares) every 3 months thereafter until the RSU is fully vested on December 31, 2029. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement.